Personalis
1330 O’Brien Drive
Menlo Park
California
94025
United States
Tel: 1-650-752-1300
Website: http://www.personalis.com/
215 articles about Personalis
-
Personalis, Inc. to Present at the 2019 Immuno-Oncology 360 Conference in New York
2/5/2019
Personalis, Inc., a leader in advanced genomics for precision oncology, today announced that they are scheduled to present at the upcoming Immuno-Oncology 360° Conference in New York on Thursday, February 7, 2019 at 3:50 PM, EST.
-
Personalis Appoints Biotech Industry Executive Clinton Musil as Chief Business Officer
1/3/2019
Personalis, Inc., a leader in advanced genomics for precision oncology, today announced the appointment of Clinton Musil as Chief Business Officer. Mr. Musil will focus initially on financing strategy.
-
Personalis, Inc. to Present at the 4th Annual ICI Europe Summit 2018 in Berlin
11/27/2018
Personalis, Inc. today announced that they are scheduled to present at the upcoming ICI Europe Summit 2018 in Berlin, Germany on Wednesday, November 28, 2018 at 9.30 AM, CET.
-
Personalis, Inc. to Present at the 3rd Annual NeoAG Summit Boston
11/14/2018
- Personalis, Inc., a leader in advanced genomics for precision oncology, today announced that they are scheduled to present at the upcoming NeoAG Summit in Boston, MA on Thursday, November 15, 2018 at 4 PM ET.
-
Personalis, Inc. Launches ImmunoID NeXT, the First Platform Providing Characterization of a Tumor and Its Microenvironment From a Single Sample
11/9/2018
Personalis, a leader in advanced genomics for precision oncology, today announced the launch of its universal cancer immunogenomics platform, ImmunoID NeXT™.
-
Personalis, Inc. to Present New Data at the Society for Immunotherapy of Cancer’s (SITC) 33RD Annual Meeting
11/6/2018
Personalis, Inc. will present new data at the upcoming Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting, taking place in Washington, D.C., November 9-11, 2018.
-
Personalis Receives New Order From the VA’s Million Veteran Program – Total Contracted Now Almost 80,000 Whole Human Genomes
10/9/2018
Personalis, Inc. today announced an extension to their contract with the US Department of Veterans Affairs (VA) to sequence a further 34,000 whole human genomes for the VA’s Million Veteran Program (MVP). This brings the total of all Personalis contracts from the MVP to almost 80,000 human genomes.
-
Personalis, Inc. to Present at the 6th Annual Immuno-Oncology Summit, Boston, MA
8/30/2018
Personalis., a leading provider of advanced genomic sequencing and analytics to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies, today announced that they are scheduled to present at the Immuno-Oncology Summit in Boston, MA on August 30, 2018 at 12:15 PM ET.
-
Personalis, Inc. Receives Approval From the New York State Department of Health for Use of its ACE ImmunoID™ Platform in Cancer Immunotherapeutic Clinical Trials
7/26/2018
Personalis, Inc., a leading provider of advanced genomic sequencing and analytics for immuno-oncology (IO), today announced that it has received approval from the New York State Department of Health for use of ACE ImmunoID, its next-generation sequencing platform for the development of personalized cancer vaccines and IO biomarker discovery, in cancer immunotherapy clinical trials.
-
Personalis, Inc. Expands International Recognition of ACE© Technology with the Issuance of Chinese Patent, adding to US and UK Patents
5/15/2018
Personalis, Inc. announced that the State Intellectual Property Office of China has issued patent ZL 2013 8 00748247 for the ACE© Technology Platform.
-
Personalis Launches ImmunogenomicsID for Multidimensional Immuno-Oncology Biomarker Analysis
2/8/2018
Personalis today announced the launch of ImmunogenomicsID, a new component of the ACE ImmunoID Platform.
-
Personalis Launches Early Access Program for Cell-Free DNA ACE Exome for Tumor Neoantigens
11/16/2017
The company also stated that the program will be offered exclusively to its immuno-oncology partners.
-
Personalis Wins New Contract to Sequence >34,000 Whole Human Genomes for the VA’s Million Veteran Program
11/7/2017
The company has also developed sophisticated data systems for tracking such large numbers of human genetic samples, for efficiently processing and managing the flow of many petabytes of genetic data, and for maintaining auditable quality at large scale.
-
Personalis Receives Approval From The New York State Department Of Health For Clinical Tests Based On The ACE Exome
4/25/2017
-
Personalis Orders Ten Illumina Novaseq 6000 Systems For Immuno-Oncology Genomics And Large-Scale Whole Genome Sequencing
4/20/2017
-
Personalis Announces Scaling Sequencing Capacity, Information Systems And Operations To Support Immuno-Oncology Clinical Trials For 2017
10/13/2016
-
Personalis Awarded U.S. Department Of Veterans Affairs Contract For Whole Genome Sequencing And Data Analysis For The Million Veteran Program
10/6/2016
-
Personalis Announces Partnership With Mt. Sinai Services To Offer Its ACE Platform For Next Generation Sequencing And Interpretation To Support Tumor Molecular Profiling And Immuno-Oncology Clinical Trials In Canada
6/6/2016
-
Personalis Selected By The LSU Health New Orleans Precision Medicine Program To Provide Comprehensive Clinical Genomic Testing For Cancer And Inherited Genetic Disease
11/18/2015
-
Personalis Launches ACE ImmunoID NGS Services For Immuno-Oncology
10/8/2015